Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

105.75 -0.06 (-0.05%)
Delayed Quote Updated: 10:52 AM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
S&P 500 After-Hours Movers: MNST, RDDT Among Gainers; VEEV, LLY Among Losers in Latest Session ↗
Via Chartmill
Topics Stocks
News headline image
Edwards Lifesciences Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Edwards Life (EW) Q3 2026 Earnings Call Transcript ↗
Edwards raised its sales outlook after a quarter that beat internal projections. 
Via The Motley Fool
Topics Earnings
S&P 500 Unusual Volume Movers for Nov. 5, 2026 ↗
Via Chartmill
Topics Stocks
Edwards Lifesciences (NYSE:EW) Raises Guidance After Solid Q2 Earnings, Stock Surges 6% ↗
Via Chartmill
S&P 500 Premarket Movers for Nov. 5: Gainers and Losers ↗
Via Chartmill
Topics Stocks
News headline image
Edwards Lifesciences Highlights PASCAL, TAVR Data Showing Patient Benefits ↗
Edwards Lifesciences (NYSE:EW) highlighted new clinical data for its transcatheter tricuspid repair and transcatheter aortic valve replacement programs, including results from the CLASP IITR trial of... 
Via MarketBeat
News headline image
CLASP II TR Trial Demonstrates Superior Clinical, Quality-of-Life Benefits With Edwards PASCAL System
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Progress Trial Demonstrates Edwards TAVR Is Superior to Clinical Surveillance for Moderate AS Patients With At-Risk Features
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy? ↗
Medtronic grew revenue by 14% in the first quarter of its fiscal 2027. 
Via The Motley Fool
News headline image
FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
From Edwards Lifesciences Corporation
Via Business Wire
Stay informed with the top movers within the S&P500 index on Thursday. ↗
Via Chartmill
News headline image
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead ↗
Edwards Lifesciences (NYSE:EW) outlined a strategy centered on structural heart disease, with Chief Executive Officer Bernard Zovighian highlighting five therapy areas that the company views as its... 
Via MarketBeat
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Top S&P500 movers in Friday's session ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
News headline image
Edwards Lifesciences Comments on TAVR National Coverage Decision
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years ↗
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 7.93% on an annualized basis producing an average annual return of 17.22%. Currently, Edwards Lifesciences has a... 
Via Benzinga
News headline image
$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today ↗
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 15.06%. Currently, Edwards Lifesciences has a... 
Via Benzinga
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Edwards Lifesciences Q2 Earnings Call Highlights ↗
Edwards Lifesciences (NYSE:EW) reported stronger-than-expected second-quarter 2026 results, with management pointing to broad growth across transcatheter aortic valve replacement, transcatheter mitral... 
Via MarketBeat
Topics Earnings
Which S&P500 stocks are moving after the closing bell on Thursday? ↗
Via Chartmill
News headline image
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.